Pharma giant Dr Reddy's Laboratories (DRL) believes that Finance Minister (FM) Arun Jaitley's universal healthcare proposal in Budget 2018 is a step in the right direction.
In an exclusive conversation with CNBC-TV18's Nitya Balakrishnan, Saumen Chakraborty of DRL adds that the company will maintain its capex target of Rs 1,000 crore for FY19, and it will focus on biological research and development (R&D).
FM Arun Jaitley's universal healthcare proposal in Budget 2018 will drive up consumption in the pharmaceutical space, he said.
For more, watch accompanying video...
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!